CTOs on the Move

Relatient

www.relatient.com

 
RELATIENT mobilizes existing, real-time healthcare data to automatically build relationships and promote loyalty with the healthcare consumer, drive compliance and adherence, boost revenue, lower costs, and build lasting relationships like no other Patient Engagement and Messaging platform available today. Compatible with most EHR/PM system on the market, RELATIENT boosts productivity by completely automating necessary outreach in the categories of Appointments, Patient Payments, Health Maintenance, Satisfaction Surveys, Self-Scheduling, and Demand messaging to patients. Reach out to us, you`ll be glad you did!
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.relatient.com
  • 320 Liberty Pike Suite 115
    Franklin, TN USA 37064
  • Phone: 866.473.8160

Executives

Name Title Contact Details
Kevin Montgomery
Co-Founder and Chief Innovation Officer Profile
Raj Bhavsar
Chief Technology Officer Profile

Similar Companies

Sansum Medical Research Institute

Sansum Medical Research Institute is a Santa Barbara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TFS HealthScience

TFS was founded in 1996 and has grown to become a leading global mid-size clinical CRO focusing on small and mid-size life science customers. TFS employs more than 700 professionals throughout 21 countries and currently delivers clinical research services in more than 40 countries.

City of Winston-Salem, NC

City of Winston-Salem, North Carolina, U.S.A. Local government. Contact City Link call 311; citylink@cityofws.org

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.

getlunacare

Luna physical therapists come to you! We accept all major insurances and Medicare. Serving patients across the United States.